Lee Jennifer Kayden
Insider CIK 1801372 · RYTM EVP, Head of North America · KRYS Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2026-08-13 | 2026-08-14 | 21,601 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2026-08-13 | 2026-08-14 | 35,000 | — | $0 | 36,283 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2026-08-13 | 2026-08-14 | 21,601 | $6.80 | $146.9K | 75,834 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2026-08-13 | 2026-08-14 | 35,000 | $24.29 | $850.1K | 54,233 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2026-08-13 | 2026-08-14 | 75,834 | $117.38 | $8.90M | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2026-08-13 | 2026-08-14 | 21,601 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2026-08-13 | 2026-08-14 | 35,000 | — | $0 | 36,283 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2026-08-13 | 2026-08-14 | 75,834 | $117.38 | $8.90M | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2026-08-13 | 2026-08-14 | 21,601 | $6.80 | $146.9K | 75,834 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2026-08-13 | 2026-08-14 | 35,000 | $24.29 | $850.1K | 54,233 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2026-02-11 | 2026-02-13 | 21,650 | — | $0 | 21,650 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2026-02-11 | 2026-02-13 | 32,500 | — | $0 | 32,500 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2026-02-01 | 2026-02-03 | 9,163 | — | $0 | 27,487 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2026-02-01 | 2026-02-03 | 3,437 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2026-02-01 | 2026-02-03 | 4,512 | — | $0 | 4,512 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2026-02-01 | 2026-02-03 | 5,500 | — | $0 | 11,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2026-02-01 | 2026-02-03 | 22,612 | — | $0 | 28,470 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | F Tax w/h | 2026-02-01 | 2026-02-03 | 9,237 | $108.99 | $1.01M | 19,233 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-02-19 | 2025-02-19 | 2,035 | $57.22 | $116.4K | 5,858 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2025-02-16 | 2025-02-19 | 5,500 | — | $0 | 16,500 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2025-02-16 | 2025-02-19 | 5,500 | — | $0 | 7,893 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2025-02-14 | 2025-02-19 | 55,000 | — | $0 | 55,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2025-02-14 | 2025-02-19 | 36,650 | — | $0 | 36,650 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-02-13 | 2025-02-14 | 1,205 | $58.00 | $69.9K | 2,393 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-02-12 | 2025-02-14 | 1,205 | $56.39 | $67.9K | 3,598 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-02-12 | 2025-02-14 | 10 | $56.41 | $564 | 4,803 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-02-12 | 2025-02-14 | 600 | $56.39 | $33.8K | 4,813 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2025-02-11 | 2025-02-11 | 2,031 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-02-11 | 2025-02-11 | 1,023 | $57.51 | $58.8K | 5,417 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2025-02-11 | 2025-02-11 | 2,031 | — | $0 | 6,440 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-02-11 | 2025-02-11 | 4 | $57.50 | $230 | 5,413 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-02-10 | 2025-02-11 | 2,295 | $59.34 | $136.2K | 4,409 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-02-10 | 2025-02-11 | 1,894 | $58.39 | $110.6K | 6,704 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2025-02-09 | 2025-02-11 | 4,189 | — | $0 | 21,601 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2025-02-09 | 2025-02-11 | 3,437 | — | $0 | 3,437 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2025-02-09 | 2025-02-11 | 4,189 | $6.80 | $28.5K | 8,598 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2025-02-09 | 2025-02-11 | 3,437 | — | $0 | 4,409 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-02-05 | 2025-02-07 | 1,133 | $61.01 | $69.1K | 1,172 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-02-05 | 2025-02-07 | 200 | $61.95 | $12.4K | 972 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-02-05 | 2025-02-07 | 1,733 | $60.08 | $104.1K | 2,305 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2025-02-04 | 2025-02-04 | 1,447 | $59.43 | $86.0K | 4,038 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2025-02-01 | 2025-02-04 | 4,513 | — | $0 | 9,024 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2025-02-01 | 2025-02-04 | 4,513 | — | $0 | 5,485 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-11-11 | 2024-11-13 | 28,717 | — | $0 | 71,283 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-11-11 | 2024-11-13 | 11,642 | — | $0 | 37,108 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-11-11 | 2024-11-13 | 20,622 | — | $0 | 25,790 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-11-11 | 2024-11-13 | 20,622 | $6.80 | $140.2K | 27,474 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2024-11-11 | 2024-11-13 | 200 | $68.43 | $13.7K | 972 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2024-11-11 | 2024-11-13 | 11,070 | $67.56 | $747.9K | 1,172 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2024-11-11 | 2024-11-13 | 17,540 | $66.95 | $1.17M | 12,242 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2024-11-11 | 2024-11-13 | 38,051 | $65.68 | $2.50M | 29,782 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-11-11 | 2024-11-13 | 11,642 | $30.66 | $356.9K | 67,833 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-11-11 | 2024-11-13 | 28,717 | $24.29 | $697.5K | 56,191 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2024-03-20 | 2024-03-22 | 9,169 | $38.22 | $350.4K | 15,918 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2024-03-20 | 2024-03-22 | 9,066 | $39.33 | $356.6K | 6,852 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2024-03-19 | 2024-03-19 | 15,515 | $39.22 | $608.5K | 25,087 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2024-02-16 | 2024-02-21 | 67,000 | — | $0 | 67,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2024-02-16 | 2024-02-21 | 22,000 | — | $0 | 22,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award | 2024-02-16 | 2024-02-21 | 33,750 | — | $0 | 40,602 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2024-02-13 | 2024-02-13 | 615 | $49.83 | $30.6K | 6,852 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2024-02-12 | 2024-02-13 | 1,023 | $51.38 | $52.6K | 7,467 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-02-11 | 2024-02-13 | 2,031 | — | $0 | 2,031 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-02-11 | 2024-02-13 | 2,031 | — | $0 | 8,490 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-02-09 | 2024-02-13 | 3,438 | — | $0 | 6,874 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-02-09 | 2024-02-13 | 3,438 | — | $0 | 6,459 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2024-02-01 | 2024-02-05 | 4,513 | — | $0 | 13,537 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2024-02-01 | 2024-02-05 | 4,513 | — | $0 | 4,513 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2024-02-01 | 2024-02-05 | 1,492 | $45.06 | $67.2K | 3,021 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2023-11-14 | 2023-11-16 | 12,030 | — | $0 | 46,412 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2023-11-14 | 2023-11-16 | 13,677 | $32.01 | $437.8K | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2023-11-14 | 2023-11-16 | 12,030 | $6.80 | $81.8K | 13,677 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2023-11-09 | 2023-11-13 | 3,438 | — | $0 | 58,442 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2023-11-09 | 2023-11-13 | 3,438 | $6.80 | $23.4K | 5,085 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2023-11-09 | 2023-11-13 | 1,719 | $28.00 | $48.1K | 1,647 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2023-11-09 | 2023-11-13 | 1,719 | $27.37 | $47.0K | 3,366 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2023-11-08 | 2023-11-13 | 5,712 | — | $0 | 61,880 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2023-11-08 | 2023-11-13 | 5,712 | $6.80 | $38.8K | 7,359 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2023-11-08 | 2023-11-13 | 3,479 | $28.64 | $99.6K | 3,880 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2023-11-08 | 2023-11-13 | 2,233 | $29.31 | $65.4K | 1,647 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2023-11-03 | 2023-11-07 | 80 | — | $0 | 67,592 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2023-11-03 | 2023-11-07 | 80 | $6.80 | $544 | 1,727 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2023-11-03 | 2023-11-07 | 80 | $28.00 | $2.2K | 1,647 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2023-09-05 | 2023-09-07 | 4,519 | — | $0 | 67,672 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2023-09-05 | 2023-09-07 | 6,166 | $28.05 | $173.0K | 1,647 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2023-09-05 | 2023-09-07 | 4,519 | $6.80 | $30.7K | 7,813 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2023-08-09 | 2023-08-09 | 1,718 | — | $0 | 72,191 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2023-08-09 | 2023-08-09 | 1,718 | $6.80 | $11.7K | 5,012 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2023-08-09 | 2023-08-09 | 1,718 | $24.66 | $42.4K | 3,294 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2023-08-07 | 2023-08-09 | 8,591 | — | $0 | 73,909 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2023-08-07 | 2023-08-09 | 8,591 | $6.80 | $58.4K | 14,517 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2023-08-07 | 2023-08-09 | 11,223 | $24.18 | $271.4K | 3,294 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2023-02-14 | 2023-02-14 | 635 | $26.87 | $17.1K | 4,940 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2023-02-11 | 2023-02-14 | 2,031 | — | $0 | 4,062 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2023-02-11 | 2023-02-14 | 2,031 | — | $0 | 5,575 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2023-02-09 | 2023-02-13 | 3,438 | — | $0 | 10,312 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2023-02-09 | 2023-02-13 | 1,192 | $27.66 | $33.0K | 3,556 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2023-02-09 | 2023-02-13 | 3,438 | — | $0 | 4,748 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2023-02-09 | 2023-02-14 | 1,204 | $27.51 | $33.1K | 3,544 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2023-02-01 | 2023-02-03 | 46,900 | — | $0 | 46,900 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2023-02-01 | 2023-02-03 | 18,050 | — | $0 | 18,050 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2022-02-15 | 2022-02-15 | 722 | $6.10 | $4.4K | 1,310 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise deriv | 2022-02-11 | 2022-02-15 | 2,032 | — | $0 | 6,093 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | M Exercise | 2022-02-11 | 2022-02-15 | 2,032 | — | $0 | 2,032 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2022-02-09 | 2022-02-11 | 13,750 | — | $0 | 13,750 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2022-02-09 | 2022-02-11 | 82,500 | — | $0 | 82,500 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2021-02-11 | 2021-02-16 | 8,125 | — | $0 | 8,125 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2021-02-11 | 2021-02-16 | 48,750 | — | $0 | 48,750 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2020-11-09 | 2020-11-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2020-01-31 | 2020-02-04 | 125,000 | — | $0 | 125,000 | SEC↗ |